Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹30 Cr
Revenue (TTM)
₹150 Cr
Net Profit (TTM)
₹-3 Cr
ROE
-12.7 %
ROCE
-6.3 %
P/E Ratio
--
P/B Ratio
0.6
Industry P/E
41.94
EV/EBITDA
7.6
Div. Yield
0 %
Debt to Equity
0.3
Book Value
₹105.6
EPS
₹-5
Face value
10
Shares outstanding
5,040,580
CFO
₹-0.39 Cr
EBITDA
₹12.96 Cr
Net Profit
₹-6.85 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
GKB Ophthalmics
| 14.4 | -0.7 | 13.0 | -21.8 | -20.3 | -6.6 | -0.5 |
|
BSE Healthcare
| -4.0 | -3.8 | -4.0 | 3.0 | 24.6 | 15.5 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
GKB Ophthalmics
| -47.7 | -2.8 | -9.6 | 27.5 | 12.9 | 37.7 | -56.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
GKB Ophthalmics
|
58.6 | 30.1 | 150.3 | -2.2 | -0.6 | -4.8 | -- | 0.6 |
| 87.0 | 31.7 | 54.6 | -1.1 | 3.6 | -3.5 | -- | 1.1 | |
| 1,596.8 | 26,278.7 | 6,112.8 | 847.2 | 17.2 | 9.2 | 31 | 2.7 | |
| 177.2 | 972.3 | 264.6 | 19.3 | 8.9 | 6.2 | 41.9 | 4.2 | |
| 820.6 | 9,868.5 | 6,537.7 | 207.0 | 4.6 | 11.5 | 47.7 | 5.2 | |
| 17.5 | 9.6 | 7.3 | 0.6 | 10.6 | 47.6 | 16.4 | 6.1 | |
| 1,240.5 | 12,702.4 | 1,781.6 | 341.3 | 19.8 | 12.4 | 36.5 | 4.3 | |
| 108.6 | 41.5 | 20.6 | 2.5 | 18.7 | 16.9 | 16.7 | 2.5 |
No Review & Analysis are available.
There is no Profile data available for GKB.NS.
Incorporated
1981
Chairman
KG Gupta
Managing Director
KG Gupta
Group
GKB
Headquarters
Mapusa, Goa
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The share price of GKB Ophthalmics Ltd is ₹58.63 (BSE) and ₹84.05 (NSE) as of 19-Mar-2026 IST. GKB Ophthalmics Ltd has given a return of -20.32% in the last 3 years.
Since, TTM earnings of GKB Ophthalmics Ltd is negative, P/E ratio is not available.
The P/B ratio of GKB Ophthalmics Ltd is 0.57 times as on 19-Mar-2026, a 80 discount to its peers’ median range of 2.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.58
|
|
2024
|
0.00
|
0.74
|
|
2023
|
0.00
|
0.87
|
|
2022
|
36.39
|
0.73
|
|
2021
|
0.00
|
0.66
|
The 52-week high and low of GKB Ophthalmics Ltd are Rs 91.70 and Rs 45.25 as of 19-Mar-2026.
GKB Ophthalmics Ltd has a market capitalisation of ₹ 30 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in GKB Ophthalmics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-5.86
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.